Default company panoramic image


Sisène is a french biotech company founded in 2007 developing innovative treatments in cancer and ophthalmology.

  • Stage Concept Only
  • Industry Not Set
  • Location Saint-Sulpice-les-Champs, Limousin, France
  • Currency EUR

Company Summary

Sisene develops a new generation of antiangiogenic drugs with an original mode of action, at least as active as the previous ones, with lower expected side effects, especially because these products are derived from physiological proteins existing in the body of the patients (blood and tissues).
One of them , NOV C- ter, C terminal part of NOV ( Nephroblastoma Overexpressed ), a physiological protein, is an innovative patented product which has


  • Default avatar
    Jean Marsac

    MD, PhD, AMP Harvard Business School, Professor of Medicine.
    Former Executive VP Roussel Uclaf, Synthelabo and Sanofi Groups.
    CEO of Sisène

  • Default avatar
    Martine Garreau

    MD, Msc Bioinformatics.
    Former Head of International Product Development & Strategic Marketing, Sanofi.
    GMG Life Sciences Consulting Manager.
    General Manager of Sisène